Side effects of losartan hctz
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Losartan HCTZ
Introduction to Losartan HCTZ
Losartan, often combined with hydrochlorothiazide (HCTZ), is a widely used medication for managing hypertension. This combination leverages the angiotensin II receptor-blocking properties of losartan and the diuretic effects of HCTZ to effectively lower blood pressure. However, like all medications, it comes with potential side effects.
Common Side Effects
Dizziness
One of the most frequently reported side effects of losartan, whether used alone or in combination with HCTZ, is dizziness. Clinical trials have shown that the incidence of dizziness in patients taking losartan is slightly higher than in those taking a placebo (2.4% vs. 1.3%) 1. This side effect is generally mild and tends to diminish as the body adjusts to the medication.
Cough
Patients switching to losartan/HCTZ from other antihypertensive therapies, particularly those involving ACE inhibitors, often report a significant reduction in the occurrence of cough. This improvement is notably greater with losartan/HCTZ compared to enalapril/HCTZ 2.
Metabolic Effects
Uric Acid Levels
Losartan has a unique effect on uric acid levels. Unlike many other antihypertensive agents, losartan can decrease serum uric acid and increase its excretion, which is beneficial for patients with thiazide-induced hyperuricemia. Studies have shown that losartan does not increase the risk of acute urate nephropathy, making it a safer option for patients with elevated uric acid levels 3.
Blood Glucose and Lipid Levels
In diabetic patients, the combination of losartan and HCTZ has been shown to manage blood pressure effectively without significant adverse metabolic effects. Both treatments significantly reduced urinary albumin excretion and improved arterial stiffness, with no notable differences in metabolic changes between monotherapy and combination therapy 7.
Serious Adverse Events
Severe Hypertension Management
In patients with severe hypertension, losartan/HCTZ has been found to be effective and well-tolerated. However, drug-related adverse experiences were reported in 22.9% of patients, with serious adverse experiences occurring in 1.5% of cases. Despite these occurrences, the overall discontinuation rate due to adverse effects was relatively low at 4.6% 9.
Exercise Tolerance and Quality of Life
In patients with left ventricular diastolic dysfunction and exertional hypertension, losartan has been shown to improve exercise tolerance and quality of life significantly. In contrast, HCTZ alone did not show similar benefits and was associated with a decrease in oxygen consumption 5.
Conclusion
Losartan combined with HCTZ is generally well-tolerated and effective in managing hypertension, with a side effect profile that includes dizziness and a beneficial impact on uric acid levels. While serious adverse events are rare, they do occur and should be monitored. The combination therapy is particularly advantageous for patients with metabolic concerns and those experiencing side effects from other antihypertensive medications.
Sources and full results
Most relevant research papers on this topic